Literature DB >> 26694050

Arteriovenous Fistula Development in the First 6 Weeks after Creation.

Michelle L Robbin1, Tom Greene1, Alfred K Cheung1, Michael Allon1, Scott A Berceli1, James S Kaufman1, Matthew Allen1, Peter B Imrey1, Milena K Radeva1, Yan-Ting Shiu1, Heidi R Umphrey1, Carlton J Young1.   

Abstract

PURPOSE: To assess the anatomic development of native arteriovenous fistula (AVF) during the first 6 weeks after creation by using ultrasonographic (US) measurements in a multicenter hemodialysis fistula maturation study.
MATERIALS AND METHODS: Each institutional review board approved the prospective study protocol, and written informed consent was obtained. Six hundred and two participants (180 women and 422 men, 459 with upper-arm AVF and 143 with forearm AVF) from seven clinical centers underwent preoperative artery and vein US mapping. AVF draining vein diameter and blood flow rate were assessed postoperatively after 1 day, 2 weeks, and 6 weeks. Relationships among US measurements were summarized after using multiple imputation for missing measurements.
RESULTS: In 55% of forearm AVFs (68 of 124) and 83% of upper-arm AVFs (341 of 411) in surviving patients without thrombosis or AVF intervention prior to 6 weeks, at least 50% of their 6-week blood flow rate measurement was achieved at 1 day. Among surviving patients without thrombosis or AVF intervention prior to week 2, 70% with upper-arm AVFs (302 of 433) and 77% with forearm AVFs (99 of 128) maintained at least 85% of their week 2 flow rate at week 6. Mean AVF diameters of at least 0.40 cm were seen in 85% (389 of 459), 91% (419 of 459), and 87% (401 of 459) of upper-arm AVFs and in 40% (58 of 143), 73% (104 of 143), and 77% (110 of 143) of forearm AVFs at 1 day, 2 weeks, and 6 weeks, respectively. One-day and 2-week AVF flow rates and diameters were used to predict 6-week levels, with 2-week prediction of 6-week measures more accurate than those of 1 day (flow rates, R(2) = 0.47 and 0.61, respectively; diameters, R(2) = 0.49 and 0.82, respectively).
CONCLUSION: AVF blood flow rate at 1 day is usually more than 50% of the 6-week blood flow rate. Two-week measurements are more predictive of 6-week diameter and blood flow than those of 1 day. US measurements at 2 weeks may be of value in the early identification of fistulas that are unlikely to develop optimally. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2015        PMID: 26694050      PMCID: PMC4851120          DOI: 10.1148/radiol.2015150385

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

1.  US vascular mapping before hemodialysis access placement.

Authors:  M L Robbin; M H Gallichio; M H Deierhoi; C J Young; T M Weber; M Allon
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

2.  Brachial and antebrachial arterial patterns; a study of 750 extremities.

Authors:  L J MCCORMACK; E W CAULDWELL; B J ANSON
Journal:  Surg Gynecol Obstet       Date:  1953-01

3.  Factors associated with early failure of arteriovenous fistulae for haemodialysis access.

Authors:  V Wong; R Ward; J Taylor; S Selvakumar; T V How; A Bakran
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-08       Impact factor: 7.069

4.  Hemodialysis vascular access survival: upper-arm native arteriovenous fistula.

Authors:  Bradley S Dixon; Lisa Novak; Jerry Fangman
Journal:  Am J Kidney Dis       Date:  2002-01       Impact factor: 8.860

5.  Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients.

Authors:  M Allon; M E Lockhart; R Z Lilly; M H Gallichio; C J Young; J Barker; M H Deierhoi; M L Robbin
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

Review 6.  Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

7.  Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis.

Authors:  Jan H M Tordoir; Patrick Rooyens; Ruben Dammers; Frank M van der Sande; Michiel de Haan; Tik Ien Yo
Journal:  Nephrol Dial Transplant       Date:  2003-02       Impact factor: 5.992

8.  Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping.

Authors:  J A Vassalotti; A Falk; E D Cohl; J Uribarri; V Teodorescu
Journal:  Clin Nephrol       Date:  2002-09       Impact factor: 0.975

9.  Hemodialysis arteriovenous fistula maturity: US evaluation.

Authors:  Michelle L Robbin; Nathan E Chamberlain; Mark E Lockhart; Michael H Gallichio; Carlton J Young; Mark H Deierhoi; Michael Allon
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

10.  Tailoring the initial vascular access for dialysis patients.

Authors:  Klaus Konner; Tempie E Hulbert-Shearon; Erik C Roys; Friedrich K Port
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  29 in total

1.  Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study.

Authors:  Alfred K Cheung; Peter B Imrey; Charles E Alpers; Michelle L Robbin; Milena Radeva; Brett Larive; Yan-Ting Shiu; Michael Allon; Laura M Dember; Tom Greene; Jonathan Himmelfarb; Prabir Roy-Chaudhury; Christi M Terry; Miguel A Vazquez; John W Kusek; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2017-07-14       Impact factor: 10.121

2.  Three-dimensional US for Quantification of Volumetric Blood Flow: Multisite Multisystem Results from within the Quantitative Imaging Biomarkers Alliance.

Authors:  Oliver D Kripfgans; Stephen Z Pinter; Cristel Baiu; Matthew F Bruce; Paul L Carson; Shigao Chen; Todd N Erpelding; Jing Gao; Mark E Lockhart; Andy Milkowski; Nancy Obuchowski; Michelle L Robbin; Jonathan M Rubin; James A Zagzebski; J Brian Fowlkes
Journal:  Radiology       Date:  2020-06-30       Impact factor: 11.105

3.  A Patient with Hemodialysis Access Problems.

Authors:  Vandana Dua Niyyar; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-18       Impact factor: 8.237

Review 4.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

5.  Postoperative Ultrasound, Unassisted Maturation, and Subsequent Primary Patency of Arteriovenous Fistulas.

Authors:  Crystal A Farrington; Michelle L Robbin; Timmy Lee; Jill Barker-Finkel; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-23       Impact factor: 8.237

6.  Association of Preexisting Arterial Intimal Hyperplasia with Arteriovenous Fistula Outcomes.

Authors:  Michael Allon; Silvio H Litovsky; Yingying Zhang; Ha Le; Alfred K Cheung; Yan-Ting Shiu
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-23       Impact factor: 8.237

7.  Early Predictors of Arteriovenous Fistula Maturation: A Novel Perspective on an Enduring Problem.

Authors:  Crystal A Farrington; Michelle L Robbin; Timmy Lee; Jill Barker-Finkel; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2020-05-18       Impact factor: 10.121

8.  Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas.

Authors:  Laisel Martinez; Juan C Duque; Marwan Tabbara; Angela Paez; Guillermo Selman; Diana R Hernandez; Chad A Sundberg; Jason Chieh Sheng Tey; Yan-Ting Shiu; Alfred K Cheung; Michael Allon; Omaida C Velazquez; Loay H Salman; Roberto I Vazquez-Padron
Journal:  J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 10.121

9.  Listening to music during arteriovenous fistula surgery alleviates anxiety: A randomized single-blind clinical trial.

Authors:  Sanem Guler Cimen; Ebru Oğuz; Ayse Gokcen Gundogmus; Sertac Cimen; Fatih Sandikci; Mehmet Deniz Ayli
Journal:  World J Transplant       Date:  2020-04-29

10.  Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Authors:  Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum
Journal:  Am J Nephrol       Date:  2018-08-02       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.